On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now

Blog


ChineseInvestors.com, Inc. (CIIX) Readies Spin Off of CBD Biotech Co. Ltd. Subsidiary and Retains Underwriter for IPO

  • CIIX recently hired Boustead Securities LLC as underwriter for the planned IPO of its wholly owned subsidiary, CBD Biotech
  • Warren Wang, CEO of CIIX, said that the move is part of its strategic plan, as CIIX looks to return to its root activities in education and consulting with companies seeking to raise profile within the investment community
  • Boustead Securities would serve as IPO sponsor and underwriter, CIIX said

ChineseInvestors.com, Inc.’s (OTCQB: CIIX) retention of Boustead Securities LLC for its anticipated IPO of wholly owned foreign enterprise CBD Biotech will enable the company to focus on its revenue base in video and online education, investor relations services and subscription activities. At the same time, CIIX plans to secure a separate exchange listing for CBD Biotech (http://ibn.fm/aS1BM).

In a news release, Warren Wang, CEO of CIIX, said, “Additionally, we believe that listing on a national exchange speaks to the quality of CBD Biotech, will provide us with market visibility and access to capital, and further support our growth strategy.”

Dan McClory, Boustead Securities’ managing director, head of China and head of equity capital markets, was optimistic. “We believe CBD Biotech can potentially gain a first mover advantage in the Chinese CBD market and could be well received in the public markets,” he noted in a news release.

CIIX sees CBD Biotech delivering higher CBD product distribution in FY2019, both domestically and in China. It reported an 800 percent increase in product sales led by ChineseHempOil.com, Inc. during its fiscal first quarter of 2019. CIIX recorded 70 percent higher YOY sales for the same fiscal quarter (http://ibn.fm/cGO9x).

For more information, visit the company’s website at www.ChineseInvestors.com

Last Tweets

Follow us: @Buy_Stocks_Now

From Our Blog

Pressure BioSciences Inc.’s (PBIO) PCT Platform Featured in 15 Independent Scientific Presentations

June 24, 2019

The presentations were held during the annual American Society of Mass Spectrometry conference – an event attended by more than 10,000 scientists Research focused on a wide range of applications ranging from cancer research to biomarker discovery The number of PCT-related presentations during the 2019 conference exceeded prior Pressure BioSciences records for a scientific meeting, […]

Rotate your device 90° to view site.